Progresses Of ADC Technology For Cancer Therapy

ADC, full name is antibody-drug conjugates. It is a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. To date, a total of 14 ADCs have been approved by the FDA. More than 100 clinical trials are underway studying their effectiveness in the treatment of blood, lung, …

Read More »